Cognitive Neuroscience Market is set to witness a 4.6% CAGR growth during the year 2022-2031

According to the latest research by Future Market Insights, Cognitive neuroscience market is set to witness a 4.6% CAGR growth during the year 2021-2031. The market has been a moderately competitive market developing at a rapid rate and is anticipated to observe lucrative growth with rising cases of neurological disorders that include Parkinson’s, Alzheimer’s diseases, and other dementias are projected to drive the market growth.

Also, neuroscience-based initiatives by government bodies, high influencing factors, such as current brain mapping research and investigation ventures, and technological advancements in algorithms and tools that are applied in neuroscience space, are anticipated to propel the market growth.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14154

What is Driving Demand for Cognitive Neuroscience?

The rising number of brain-related disorders and the number of advanced healthcare systems are certain driving factors for the market.

Furthermore, key factor that has accelerated the research studies in this arena is the growth in the number of various malignant CNS disorders such as Parkinsonism and Alzheimer’s disease. As geriatric population is prone to various central nervous systems associated disorders such as schizophrenia, Alzheimer’s, and Parkinsonism, with growth in the older population, this market is anticipated to witness lucrative growth.

Also, constant launch of novel products by major participants in the market to fight several neurological disorders is anticipated to increase Y-O-Y growth of this market.

Surge in Number of Deaths Due to Neurological Disorders likely to boost the Cognitive Neuroscience Sales

The rising incidents of neurological disorders, which include Parkinson’s, Alzheimer’s, and other brain-related disorders are expected to encourage participants in the cognitive neuroscience market to help combat such disorders. In 2018, over one hundred thousand people died because of Alzheimer’s in the United States.

Also, rising number of neurological disorder cases are expected to increase the number of deaths occurring due to these disorders. Moreover, the government bodies are growing the medical expenditure to support development of medical facilities in neuroscience leading to development of the market.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14154

US and Canada Cognitive Neuroscience Market Outlook

United States and Canada led the Cognitive Neuroscience market. U.S. Cognitive Neuroscience market is anticipated to witness noteworthy growth owing the existence of neuroscience based research organizations as well as availability of advanced healthcare systems.

Moreover, large organizations and many neuroscientists are spreading knowledge and awareness through programs concerning the brain system in government as well public offices. Also, rise in number of deaths associated with neurological disorders is one of the key factors for the development of the market in U.S.

Europe Demand Outlook for Cognitive Neuroscience

Europe is second leading market and is anticipated to register a significant growth because of the growing burden of neurological diseases in Europe and the availability of large manufacturers in the region.

In 2017, as per ‘The burden of neurological diseases in Europe’ report, over a million deaths occurred in the WHO European region due to neurological diseases. It lead towards a high demand for the growth of the cognitive neuroscience market.

Who are the Key Manufacturers and Suppliers of Cognitive Neuroscience?

Some of the leading manufacturers and suppliers of cognitive neuroscience include

  • Siemens Healthineers
  • Scientifica Ltd.
  • Alpha Omega Inc.
  • GE Healthcare
  • Biobserve GmbH
  • NeuroNexus Technology
  • Laserglow Technologies
  • Kendall Research Systems LLC and others.

The cognitive neuroscience market is moderately competitive, with the existence of a large number of players in global markets. Key players in the market are focusing on mergers & acquisitions and partnerships with other small players. Moreover, companies are also concentrating on research activities and new product launches.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/14154

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

EMG Biosensors Market 2021: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2031

According to the latest research by Fact.MR, EMG biosensors market is set to experience steady growth during the year 2021-2031. With increasing importance of continuous health monitoring, the market according to research conducted by Fact.MR will see a steady growth over the forecast period of 2021-2031 with a CAGR of around 6.7%.

Skeletal muscles in the human body carry out their function of contracting and relaxing with help of electrical signals directed by the brain. EMG or Electromyograph is type of device that measure this electrical activity. Any variation in these patterns can point to a disturbance in the standard muscular function. This activity can be widely measured and analysed in two forms; pattern recognition and signal intensity.

EMG Biosensors Market study by “Future Market Insights” provides details about the market dynamics affecting the market, Covid-19 Impact, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-14216

This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.

The report EMG Biosensors Market gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2018 to 2028 with respect to major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the EMG Biosensors Market.

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting EMG Biosensors Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Leading EMG Biosensors Market Players:

  • Biometrics Ltd. (US)
  • Delsys Incorporated (US)
  • Butler Technologies (Ireland)
  • iMotions (Denmark)
  • EB Neuro S.p.A. (Italy)
  • Compumedics NeuroScan (United States)
  • OpenBCI (US)
  • Ceribell Inc. (United States)

Key Elements that the report acknowledges:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-14216

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Pulmonology Lasers Market By Technology, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Forecast, 2022 – 2031

Pulmonology Lasers Market OverviewAccording to the latest research by Future Market Insights, the Pulmonology Lasers Market will witness growth during 2021-2031. Any type of cancer is rapidly mutating and presenting a challenge for the researchers to keep up with these mutations and develop effective treatments for them. 

Lung cancer being one of the concerning risers. Prevalence of this cancer is increasing day-by-day as per the European Union and the Cancer.org. This will directly affect research and development into lung cancer in finding ways to effectively treat it and hence boosting the market growth with a CAGR of around 12.4%.

What is Driving Demand for Pulmonology Lasers Market?Pulmonary Lasers use thermal – ablation technique where cutting and coagulation properties is used to treat complication related to the airway tract. It can act as a palliative as well as curative therapy which relieves the obstructions in the airway caused due to various complications like neoplasms, tumours, lesions, etc.

Most crucial driver of the market is that this laser therapy provides curative effect for lung cancer (early stage) as well as palliative care of central airway obstruction due to a number of malignancies.

Another associated factor is that the growing number of cancer prevalence is making researchers to find treatments competent enough to keep up with this mutating disease.

The ever changing epidemiology of cancer as a disease will definitely boost professionals to keep innovating in order to make detection as early as possible; and possibly boosting this market.

Needle-based Confocal Laser Endomicroscopy (nCLE) – A lung Cancer Detection ToolIt is very challenging to successfully diagnose peripheral lung cancer with traditional bronchoscope because some target lesions can be missed out. So, a BMJ Journal article explored the feasibility of a new microscopic laser needle in order to accurately detect the lesions present in the airway.

This new technique helps in visualising the site in real time to detect these lesions. This 2021 study concluded that, this imaging and laser combo is feasible, safe and allows real-time lung cancer lesion detection. Accurate distinguishing of airway parenchyma from lung cancer lesions was seen with the help of this guidance tool.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-14221

U.S. and Canada Pulmonology Lasers Market As per Cancer.org, 235,760 new lung cancer cases and 131,880 deaths due to lung cancer are estimated in 2021 in the US. These statistics are definitely an ally to the market growth of pulmonology lasers in the country and will drive the market towards a positive side.

Authorities here are now focusing more on investments in R&D to improve the management and treatment of these lung cancer. This collectively makes US a front runner in the pulmonology lasers market in North America region.

Europe Pulmonology Lasers Market According to data published by European Union, 312,000 European people get affected from lung cancer every year. Owing to this, demand for advanced and swift treatment along with early detection for lung cancer is increasing. Furthermore, the rising technological advancement and increasing investment in R&D is expected to drive the market growth during the forecast period.

Who are the Key Manufacturing and Supplying Companies in Pulmonology Lasers Market?Key players:

  • Quanta System
  • Hyper Photonics
  • Richard Wolf
  • Lumenis
  • Cook Medical
  • Edap Tms
  • Olympus Corporation
  • EMS
  • Cooltouch
  • Convergent Laser Technologies
  • AMS
  • Jena Surgical
  • Solar Laser Systems
  • Potent Medical
  • Candela Medical

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Pulmonology Lasers Market Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14221

Key SegmentsBy Laser Type: 

  • Neodymium-doped Yttrium Aluminium Garnet (Nd-YAG)
  • Photodynamic

By Indication:

  • Bronchogenic Carcinoma
  • Malignant Lesions
  • Benign Tumours
  • Neoplasms
  • Haemorrhage
  • Tracheal Stenosis
  • Non-small Cell Lung Cancer
    •  carcinoid
    •  cystic carcinoma
    •  mucoepidermoid carcinoma
    •  endobronchial metastases

By End User:

  • Hospitals
  • Speciality Care Centres
  • Academic and Research Institutions

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Neurology Digital Therapeutics Market to Witness Excellent Revenue Growth, Overview, Emerging Trends And Forecast to 2021-2031

Neurology digital therapeutics is the field of healthcare that deals with and prevents medical conditions using information and communication technology. According to the recent research by FMI, the neurology digital therapeutics market is anticipated to witness a 9.0% growth during the forecast period from 2021 to 2031. This significant growth will be experienced due to the advancement in technology in the healthcare sector. Therefore, neurology digital therapeutics demand is expected to increase significantly soon.What is Driving Demand for Neurology Digital Therapeutics?

Various factors are driving the demand for neurology digital therapeutics such as it optimizes the time of administrative tasks and routine communication, it reduces the pain associated with the traditional therapeutic methods, it make the monitoring easier and more accurate.

These technologies can also be used for therapy and rehabilitation purposes with the help of smartphones, tablets and computers.

Also, neurological digital therapeutics can overcome various problems related to traditional clinical practices. Thus, all these factors have the potential to drive the demand of the market during the forecast period from 2021 to 2031.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-14231
Advancement in Information Technology Likely to Augment Neurology Digital Therapeutics

Information technology work in conjugation with the drugs to give maximum benefit of the treatment to the patients. Patients can take care of their health through easy-to-use apps and monitoring devices. Start-ups are introducing different innovative ideas to attract investors.

Also, the prevalence of chronic diseases is rising in the world that creating opportunities for healthcare and digital therapy players to invest in the market by innovating and launching technological advanced devices and enhance the neurological digital therapeutics demand globally.

The treatment of chronic diseases with the traditional method is becoming a challenging thing for healthcare workers and manufacturers due to its increasing burden. Thus, innovative technology or digital therapeutics is required for the treatment of a large number of populations suffering from chronic diseases.

Thus, it is expected to boost the market of neurology digital therapeutics during the forecast period from 2021 to 2031 in the world.

The U.S. and Canada Neurology Digital Therapeutics Market Outlook

U.S. and Canada remain the predominant market for neurology digital therapeutics because of the presence of key players in the region. For instance, Pear Therapeutics headquartered in the U.S. operates at the intersection of biology and software technology. The company discovers, develops, and delivers clinically certified software to provide better outcomes for patients using neurological digital therapeutics.

Thus, the demand for neurology digital therapeutics will increase in the region during the forecast period from 2021 to 2031.

Europe Demand Outlook for Neurology Digital Therapeutics

The demand for neurology digital therapeutics will be increased in Europe because of a rising number of chronic disease amongst patients with rising geriatric populations in the region.

With increasing age, the chances of developing chronic diseases also increase in the region.

According to EUROSTAT, in 2020, there were 20.6% of people in Europe were more than 65 years of age.

Thus, there will be growth in the neurology digital therapeutics market in the region during the forecast period from 2021 to 2031.

Who are the Key Manufacturers and Suppliers of Neurology Digital Therapeutics?

The key players of neurology digital therapeutics include

  • Livongo Health
  • Noom
  • Omada Health
  • Pear Therapeutics
  • WellDoc
  • Proteus Digital Health
  • Propeller Health
  • Akili Interactive Labs
  • Mango Health
  • Better Therapeutics
  • Happify
  • Kaia Health
  • Click Therapeutics and others.

They follow certain strategies to survive in the market like a product launch, product approval, patent gaining, expansion, acquisition and merger. For instance, in October 2021, Pear Therapeutics announced about continuing the expansion of intellectual property portfolio for prescription digital therapeutics.

The Report Covers Exhaustive Analysis on:

  • Neurology Digital Therapeutics market  Segments
  • Neurology Digital Therapeutics market  Dynamics
  • Neurology Digital Therapeutics Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14231

Regional Analysis Includes:

  • North America (U.S., Canada)
  • Latin America ( Brazil, Mexico, Argentina, Rest of Latin America)
  • Europe (Germany, Italy, UK, Spain, France, Russia, Rest of Europe)
  • South Asia (India, Indonesia, Malaysia, Thailand, Rest of South Asia)
  • East Asia (Japan, South Korea, China)
  • Oceania ( Australia, New Zealand)
  • The Middle East and Africa (GCC, Turkey, South Africa, Rest Of MEA)

Report Highlights:           

  • Detailed overview of Neurology Digital Therapeutics market
  • Changing market dynamics in the industry
  • In-depth Neurology Digital Therapeutics market  segmentation
  • Historical, current and projected market size in terms of volume and value.

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Key SegmentsBy Product Type:

  • Software
  • Devices

By Indication:

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Others

By End User:

  • Hospital
  • Clinics
  • Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14231

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Clinical Oncology Next-generation Sequencing Market is expected to growing at a CAGR of 8.8% during the forecast period of 2021-2029

Next-generation sequencing refers to the identification of the nucleotides of DNA base pairs for the diagnosis of various diseases. Oncology is one of the important applications of next-generation sequencing. It is an advanced and faster method of sequencing. Clinical oncology next-generation sequencing includes kits & reagents, services, sequencing platforms, and sequencing products. The kits and reagents used for sequencing are expected to witness significant growth in the overall market.

North America is expected to be a prominent region in the global clinical oncology next-generation sequencing market owing to the presence of well-developed healthcare infrastructure and numerous technological advancements in the region. North America and Europe are expected to witness a significant growth rate in the clinical oncology next-generation sequencing market.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/clinical-oncology-next-generation-sequencing-market

Synthesis Sequencing Technology to Hold a Major Market Value Share

Based on the technology, the clinical oncology next-generation sequencing market has been segmented into pyro sequencing, sequencing by synthesis (SBS), and Single-Molecule Real-Time Sequencing (SMRT), nanopore sequencing, ligation sequencing, and reversible dye termination sequencing. Synthesis sequencing is however expected to hold a significant share in the clinical oncology next-generation sequencing market. Ion semiconductor sequencing is a method of DNA sequencing in which hydrogen ions are detected based on the polymerisation of DNA. Pyro-sequencing includes identifying the order of nucleotides in DNA based on the “sequencing by synthesis” principle, in which the sequencing is performed with the help of DNA polymerase. SBS is a technique used to determine the series of base pairs in DNA, which also known as DNA is sequencing.

There are various applications associated with clinical oncology next-generation treatment market. They include whole tumor genome sequencing, whole tumour exome sequencing, targeted tumour genome profiling, tumour transcriptome sequencing, tumour-normal comparisons, and other applications. Targeted tumor genome profiling is expected to hold a large share of the clinical oncology next-generation treatment market. On the basis of end user, the clinical oncology next-generation sequencing market has been segmented into hospital laboratories, clinical research organisations, diagnostic laboratories, and others. Clinical research laboratories are expected to hold a large revenue share in the clinical oncology next-generation sequencing market.

Apart from the factors driving the clinical oncology next-generation sequencing market, there are few factors that are likely to hinder the overall growth of the clinical oncology next-generation sequencing market, such as high costs associated with the establishment of sequencing platforms, low quality of outsourcing services, and inadequate availability of sequencing platforms in some regional markets. On the other hand, increasing biomedical research using clinical oncology, increasing government funding for life science projects, substantial decline in the prices of sequencing, and technological advancements in the field of sequencing are some of the major factors driving the growth of the clinical oncology next-generation sequencing market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9543

Tier 1 Companies Hold Nearly 3/5th Share of Global Market Value

The report tracks some of the key companies operating in the clinical oncology next-generation sequencing market such as QIAGEN N.V., Thermo Fisher Scientific., Pacific Biosciences of California, Inc., F. Hoffmann-La Roche Ltd Oxford Nanopore Technologies, Ltd., Takara Bio, Inc., Illumina Inc., PerkinElmer Inc.and Agilent Technologies, Inc. Thermo Fischer Scientific, Oxford Nanopore Technologies Ltd., and Illumina are expected to hold a signficant share of the clinical oncology next-generation sequencing market. These first tier companies hold a share of approximately 60% in the clinical oncology next-generation sequencing market.

CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET TAXONOMY

The global clinical oncology next generation sequencing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Product

• Sequencing Platforms
• Sequencing Products
• Kits and Reagents
• Services

By Technology

• Ion Semiconductor Sequencing
• Pyro-Sequencing
• Synthesis Sequencing (SBS)
• Real Time Sequencing (SMRT)
• Ligation Sequencing
• Reversible Dye Termination Sequencing
• Nano-Pore Sequencing

By Application

• Whole Tumor Genome Sequencing
• Whole Tumor Exome Sequencing
• Targeted Tumor Genome Profiling
• Tumor Transcriptome Sequencing
• Tumor-normal Comparisons
• Others

By End User

• Hospital Laboratories
• Clinical Research Organizations
• Diagnostic Laboratories
• Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9543

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Off-Highway Vehicle (OHV) Telematics Market to record growth at 15% CAGR over the forecast period of 2022 and 2032

ESOMAR-certified consulting firm Future Market Insights’ report, projects the global OHV telematics market to record growth at 15% CAGR over the forecast period of 2022 and 2032.

Growing demand from construction industry is accelerating OHV telematics sales across the globe. Demand for OHV telematics is rising extensively in emerging economies as are becoming more aware for the vehicle safety.

Increasing application within rental equipment companies, mining industry and for safety & security of vehicles will continue creating sales opportunities. As per the FMI’s analysis, despite the slight setback due to the pandemic, the global OHV telematics market registered the Y-o-Y growth at 14.50% CAGR during 2020-2021.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1430

What are the Growth Prospective for Off-Highway Vehicle (OHV) Telematics Market?

“Due to the increase in construction, agriculture and mining activities in the remote and inaccessible areas, there has been a growing demand for telematics trackers, geo tab devices, and geo tab dash cams. Another OHV telematics market trend shows rise in demand for mix telematics trackers and Bluetooth telematics.”

Steady recovery in automotive industry and recommencement of automotive production & manufacturing companies across the globe have improved the market growth.

Government increasing funding and initiatives towards the safety of vehicles have compelled the manufacturers to increase the adoption of telematics within the off highway vehicles.

Stringent regulations for the vehicle safety across the U.S., Germany, India, China and the U.K. is also expected to improve the adoption of OHV telematics over the coming years.

According to the FMI’s analysis, the global OHV telematics market reached a valuation of US$ 421 Mn in 2021.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1430

Key Takeaways from FMI’s OHV Telematics Market Study

  • By end-use application type, construction segment will emerge as primary OHV telematics end-user, accounting for 64.4% market share.
  • In terms of sales channel, original equipment manufacturers are the most preferred over the aftermarket service providers, exhibiting growth at over 11.4% CAGR
  • In terms of technology type, cellular technology will cement its dominance during the forecast period, expanding at 11% CAGR
  • The U.S. will emerge as the leading market across North America backed by the high demand within the construction industry
  • Japan and South Korea will collectively account for over 6% of global market share over the forecast period
  • Germany and the U.K. are anticipated to lead the Europe’s OHV telematics market, exhibiting the growth at 10.20% CAGR
  • Increasing application in precision farming will bolster the demand of off-highway vehicle telematics across India through 2021

“Growing consumer preference for advanced telematics technology in off-highway vehicles for usage in construction, mining and agriculture equipment has bolstered the adoption of telematics, generating lucrative prospects for market players,” says the FMI analyst. 

By Sales Channel
  • Original Equipment Manufacturers (OEMs)
  • Aftermarket
By Technology Type
  • Cellular
  • Satellite
By End-Use Application
  • Construction
  • Agriculture
  • Mining

Direct Purchase of this Report@ https://www.futuremarketinsights.com/checkout/1430

Competitive Landscape

TomTom International, Harman International, ORBCOMM Inc., Topcon Corporation, MiX Telematics, Navman Wireless, Omnitracs LLC, Wacker Neuson, Trackunit A/S and Zonar Systems Inc. among others are some prominent players operating in the OHV telematics market.

As per the FMI’s analysis, the market is dominated with top 5 players operating in OHV telematics market, accounting for 25% of market share. Top 5 players include, TomTom International, Harman International, MiX Telematics, ORBCOMM Inc., and Omnitracs.

Key players are adopting strategies such as adoption of artificial intelligence along with new product launches to maintain their position in the industry.

Long-term agreements with OEMs and targeted mergers & collaboration will also be one of the key strategies adopted by market players.

For instance, in April 2021, HBS systems, leading provider of web-based equipment dealership management solutions and rental software announced the launch of an advanced telematics with Kubota, an automotive dealership in North America.

Top Reports Related To Automotive Market Insights

Automotive Repair & Maintenance Services Market : Global automotive repair & maintenance services market is forecast to reach a US$ 544.5 Bn in 2021, with a stable long-term projection, as per the latest insights from Future Market Insights (FMI), an ESOMAR-certified research and consulting firm.

Automotive Glass Market : The global demand for automotive glass has declined significantly in 2020, with the Covid-19 pandemic restricting automotive production and reducing new orders in the manufacturing sector. However, long-term prospects remain bullish, with a new report by FMI projecting 4% CAGR through 2030. The report opines that market players will benefit from smart glass technology and the rising popularity of electric vehicles.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/ohv-telematics-market
Press Release Source: https://www.futuremarketinsights.com/press-release/ohv-telematics-market

Mucus Clearance Devices Market Key Players : Allergan plc, Koninklijke Philips N.V., Respiratory Technologies, Inc., Smiths Medical, Electromed, Inc.

Key Players in Mucus Clearance Devices Market Focusing on Online Distribution Channels

Leading distributers and suppliers operating in the global mucus clearance devices market are eyeing opportunities in the E-commerce sector. Online introduction and sales of innovative mucus clearance devices is being practiced by several companies to minimize costs associated with supply, distribution, and operation. Online availability also tends to attract a wider consumer base as it enables products comparison, according to research.

The rising focus of the leading medical device manufactures to launch novel mucus clearance devices such as SmartVest is expected to lead to the robust growth of the mucus clearance devices market. Smart mucus clearance devices that are being developed on a similar line of SmartVest have the smartphone-connectivity feature that allows doctors and respective hospitals to have ready access to real-time data, which can be further provided to telemedicine service providers. According to the report, such advanced technology enabled innovations will play a crucial role in boosting demand for mucus clearance devices in the near future.

Hill-Rom Inc., the global leader in mucus clearance devices landscape, currently represents an approximate 35% share in the market revenue. The report also profiles several other prominent players competing in the mucus clearance devices market, which include Allergan plc, Koninklijke Philips N.V., Respiratory Technologies, Inc., Smiths Medical, Electromed, Inc., Monaghan Medical Corporation, Dr. Burton Healthcare LLC, Actegy Limited, Westmed, Inc., International Biophysics Corporation, Thayer Medical, R. Cegla GmbH & Co. KG, Medical Acoustics LLC, VORTRAN Medical, and PARI Medical Holding GmbH.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9416

According to a recent market research study of Future Market Insights (FMI), more than 5 million units of mucus clearance devices were sold in 2018. The sales will reportedly increase by a robust 7.7% in 2019, as per the Y-o-Y growth calculated in the report. A majority of the demand for mucus clearance devices is accounted by home care settings, followed by hospitals.

HFCWO & OPEP Mucus Clearance Devices Selling Prominently

Consistently increasing prevalence of cystic fibrosis and COPD (chronic obstructive pulmonary disease) is a key factor responsible for the robust growth of the mucus clearance devices market. As per FMI’s analysis, cystic fibrosis generates the largest patient pool raising the demand for mucus clearance devices, accounting for almost half of the total sales. COPD also accounts for a significant volume share that roughly equates just-under a third of the mucus clearance devices market volume.

The demand for HFCWO (high-frequency chest wall oscillation) devices, which is more prominent in home care settings and hospitals, currently accounts for more than 1/3rd of the total market volume. The report also highlights a notable share of the sales accounted by OPEP (oscillating positive expiratory pressure) devices, i.e. over 1/4th of the total sales.

On other hand, stringent regulatory guideline by FDA for the approval of medical devices is likely to act as roadblock for the mucus clearance devices market. In addition, lack of awareness about the symptoms of cystic fibrosis and COPD in developing economies is another factor that is likely to hamper the growth of the mucus clearance devices market. Furthermore, the treatment rate for respiratory disorders is much lesser in low- and middle-income countries, which is also hampering the growth of the mucus clearance devices market.

North America is the most prominent region in the global mucus clearance devices market, with over 2/5th of the total market volume. North America’s market for mucus clearance devices is followed by Europe and East Asia, and the report points to attractive opportunities residing in India, Brazil, and South Africa.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9416

Global Mucus Clearance Device Market: Segmentation:

By Cycle Type

  • HFCWO Devices
  • OPEP Devices
  • MCA Devices
  • IPV Devices
  • PEP Devices

By Indication

  • Cystic Fibrosis
  • COPD
  • Bronchiectasis
  • Others

By End User

  • Direct / Patient
  • Hospitals
  • Fertility Clinics & IVF Centres

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9416

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Lung Cancer Surgery Market is impressive rate of ~6% CAGR, over the Forecast period 2022 – 2029

Over 2 million new cases of lung cancer were registered globally by the end of 2018, as reported by the American Cancer Society, Inc. The global lung cancer surgery landscape currently represents a US$ 1 Bn market and will expand at a strong CAGR during the period of projection, 2019 – 2029. A new Future Market Insights (FMI) report states that the use of techniques that are minimally invasive, video assisted, and robot assisted is growing, which is shaping the future of lung cancer surgery market.

Robotic thoracic surgery would remain highly preferred over traditional surgical techniques, as it offers higher magnification, more precision, and eliminate the need for large-incision operations. Development of new surgical robots may cut down the cost of devices and increase shift towards robotic lung cancer surgery. Introduction of new imaging techniques for enhancing visualization, angled lenses for enhanced accessibility, and end staplers will continue to enhance the video-assisted lung cancer surgery procedure.

Intuitive Surgical is the sole player in robotic lung cancer surgery market with its DaVinci system. Medtronic and Johnson & Johnson are developing surgical robots and are challenging the monopoly of Intuitive Surgical in lung cancer surgery market.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways – Lung Cancer Surgery Market Study

  • Introduction of powered and tissue-specific endoscopic stapling technology provides significant benefits to reduce cost, resource usage, improve clinical outcome compared to manual staplers.
    • In September 2019, Johnson & Johnson launched ECHELON CIRCULAR™ Powered Stapler for thoracic, colorectal, and gastric surgery.
    • In March 2016, Intuitive Surgical Inc. got U.S. FDA approval for its da Vinci Xi Endowrist Stapler 30 (30 mm) instruments and reloads.
  • Key market players are focusing on the development of new robot-assisted thoracic surgery system. Partnerships & collaborations with best in class surgical device and visualization technology developers are the strategic focus of manufacturers. For instance,
    • Medtronic partnered with Karl Stroz, a best in class endoscopic imaging devices manufacturer. In June 2019, Medtronic announced its upcoming robotic-assisted surgical platform including three-dimensional vision systems from Karl Stroz.
  • East Asia is expected to be the prominent region in the lung cancer surgery market during the forecast year. This is attributed to high prevalence of lung cancer in China & Japan increasing the demand for lung cancer surgery. According to the International Agency for Research on Cancer, from overall cancer patients in China and Japan, around 18.1% and 16.8% patients respectively were having lung cancer.

Development in robotic thoracic surgery platforms and innovation in tissue-specific endoscopic stapling and vessel sealing techniques to reduce endoleak complications will further broaden the growth prospects of the lung cancer surgery market.

Product Portfolio Expansion to Increase Global Footprint

Manufacturers are adopting product portfolio expansion strategy to increase their footprint in the global lung cancer surgery market. Market players such as Pentax Medical, Olympus, Johnson & Johnson, Intuitive Surgical Inc. are continuously focusing on new product launches and regulatory approvals. For instance,

  • In July 2016, PENTAX Medical launched new DEFINA high-definition pulmonology endoscopy system for crystal clear imaging during surgical procedures.
  • In April 2018, Intuitive Surgical Inc. received U.S. FDA clearance for da Vinci Vessel Sealer Extend single-use, the fully wristed bipolar electrosurgical instrument for lung cancer surgery procedures such lobectomy, segmentectomy, and wedge resection.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-396

Lung Cancer Surgery Market Structure Analysis

  • The global lung cancer surgery market represents a fragmented competition scenario. Most of the key players maintain their strategic focus on the development of advanced energy devices, introduction of new imaging technology, and joint ventures & collaborations for innovative technological development. For instance,
    • In March 2019, Titan Medical and Teleflex incorporated announced collaboration for the development of robotic ligation technology.
  • Market leaders such as Ethicon (Johnson & Johnson), Medtronic Plc. Olympus Corporation, Intuitive Surgical Inc., PENTAX Medical Company contributed more than half of the market value share in the lung cancer surgery market in 2018.
  • Robotic-assisted lung cancer surgery market is dominated by Intuitive Surgical Inc., manufacturer of da Vinci System. da Vinci System is the only robotic surgery system available for lung cancer surgery such as lobectomy.
  • For a greater hold in the target market, lung cancer surgery device manufacturers continuously emphasis on strategies, such as mergers and acquisitions. For instance, in April 2019, Johnson & Johnson completed the acquisition of Auris Health Inc. a robotic platform technology manufacturer.

Learn More About Report

The lung cancer surgery market a new study from Future Market Insights, provides unparalleled insights on evolution of the lung cancer surgery market during 2014 – 2018 and presents demand projections during 2019 – 2029 on the basis of product type (thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, and surgical energy instruments), application (lobectomy, segmentectomy, wedge resection, pneumonectomy), end user (hospitals, ambulatory surgical centers) across seven prominent regions.

Key Segment

Product

  • Surgical Energy Instruments
    • Advanced Energy Instruments
      • Advanced Bipolar Instruments
      • Ultrasonic Instruments
    • Basic Energy Instruments
      • Bipolar Instrument
      • Monopolar Instruments
  • Thoracoscopes
  • Mediastinoscopes
  • Bronchoscopes
  • Robotic-Assisted Thoracic Surgery Systems
  • Surgical Staplers

Application

  • Lobectomy
  • Segmentectomy
  • Wedge Resection
  • Pneumonectomy

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-396

End User

  • Hospitals
  • Ambulatory Surgical Centers

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Pedicle Screw Systems Market is expected to reach US$ 6.46 Billion by 2029

Global Pedicle Screw Systems Market 

A new market research report by Future Market Insights on the pedicle screw systems market includes global industry analysis 2014 – 2021 and opportunity assessment 2022 – 2029. The report investigates the pedicle screw systems market and provides critical insights for the forecast period of 2022 – 2029. As per the findings of the report, the global pedicle screw systems market is projected to experience a significant growth over the forecast period, due to number of driving factors such as increasing geriatric population with degenerative diseases across geographies.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3970 

Limited tie offer for new entrants!!! Buy reports at discounted prices!!! 

The Pedicle Screw Systems Market report highlights the following stakeholders (At least 5):

  • Medtronic plc
  • DePuy Synthes Inc
  •  Zimmer Biomet Inc
  • Stryker Corp
  • Orthofix Inc
  • NuVasive Inc.

By Region -wise Segmentation Assessment:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Download Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-3970 

The Pedicle Screw Systems Market research covers an exhaustive analysis of the following data:

  • Synopsis of recent R&D activities implemented by each Pedicle Screw Systems Market player.
  • Segmentation of the Pedicle Screw Systems Market to highlight the growth prospects and trends impacting these segments.
  • Factors (Positive and Negative) affecting the growth of the global Pedicle Screw Systems Market.
  • Comprehensive analysis of the impacts of the growth of relevant industries.
  • Exhaustive understanding of the strengths, weaknesses, opportunities and threats of various Pedicle Screw Systems Market players.

Get Full Access of the Press-Release Report @ https://www.futuremarketinsights.com/press-release/pedicle-screw-systems-market 

The Pedicle Screw Systems Market research answers the following questions: 

  1. Which country in region is expected to hold the largest share by 2014?
  2. How are the players overcoming the challenges associated with the Pedicle Screw Systems Market?
  3. What modifications are the Pedicle Screw Systems Market players performing to receive regulatory approvals in specific regions?
  4. What are the underlying micro- macroeconomic factors impacting the global Pedicle Screw Systems Market?
  5. What is future prospect of Pedicle Screw Systems Market in end use segment?

Get Full Access of the Report @ https://www.futuremarketinsights.com/reports/pedicle-screw-systems-market 

A thorough primary and secondary research has been performed to extract the nuts and bolts of the Pedicle Screw Systems Market. Various service providers, implementation vendors and research in different departments of all gamut of companies were approached to provide a clear-cut picture of the market structure. Further, DROT analysis and Porter’s Five Forces analysis are used to offer the factors (positive and negative) impacting the growth of the Pedicle Screw Systems Market.

RFID in Pharmaceuticals Market is envisaged to record a CAGR of over 8% through 2028

Future Market Insights (FMI), in its new study, finds that the radio-frequency identification (RFID) in pharmaceuticals market was valued at over US$ 950 Mn in 2018, and is estimated to register a Y-o-Y growth at approximately 10% in 2019. Prospects remain remarkable for the RFID in pharmaceuticals industry, as efficiency-led actions of players continue to enhance the reliability and accuracy of their business operations.

The study finds that drug tracing system remains the most lucrative application of RFID in pharmaceutical industry, accounting for approximately 60% sales. Efforts of the FDA, in collaboration with pharmaceutical suppliers, to maintain a secure drug supply in the wake of rising counterfeit drugs prevalence, has encouraged the pharmaceutical industry to use RFID in combination with the electronic product code (EPC) for real-time tracking, tracing, and authentication of drugs.

According to the study, such preventative measures against infiltration of counterfeit drugs are likely to have a positive economic influence on legitimate companies, who are now focusing on the deployment of anti-counterfeiting solutions. Focus of the organized players in the pharmaceutical sector to safeguard authenticity of their products, while creating moats for counterfeiters, will continue to favour growth of the RFID in pharmaceutical market.

To remain ‘ahead’ of your competitors, request for a sample

Chipless RFID Sales Remain Over 2X of Chipped RFID

According to the study, chipless RFIDs continue to gain robust attractiveness in the pharmaceutical industry, as they eliminate the hardware-related challenges associated with their chipped counterparts. Additionally, RFIDs without ICs allude at significant cost reduction of the component, in turn complementing their development and demand on a wide scale. However, complexities linked with designing and development of chipless RFID, such as data transmission and encoding, continue to sustain the demand for the chipped RFID to a certain extent. The study finds that sales of chipless RFID will remain over 2X that of the chipped RFID in 2019.

The study expects RFID reader to remain the core component in the RFID in pharmaceutical market, with growing focus of pharma suppliers on effective identification of products prior to their collection, storage and shipping. Gains in the RFID in pharmaceutical market will remain complemented by sales of RFID tags, with revenues in 2018 accounting for over one-third market share.

Adoption Remains High among Drug Manufacturers

Application diversity of RFID in pharmaceutical industry has led its adoption among a wide range of end-users that range from drug manufacturers and drug wholesalers, to hospitals and clinics. The report estimates drug manufacturers to account for leading shares of the RFID in pharmaceutical market, who are constantly emphasizing on ensuring the authenticity of their products in the market. Adoption is expected to witness high-growth among drug wholesalers and hospitals and clinics, which collectively account for over two-fifth share of the market.

The study states that North America will remain the leading market for RFID in pharmaceutical, with Europe following the suit. Supremacy of developed economies in the RFID in pharmaceutical market is significantly attributed to stringent standards & regulations implemented for serialization, and relative greater prevalence of OTC and generic drugs in these regions. Additionally, focus of players in developed markets remains strong on brand protection, and preventing packaging-related product recalls, which in turn augurs well for growth of the RFID in pharmaceutical market.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-9508

This FMI study also offers a long-term forecast of the RFID in pharmaceutical market for the period between 2018 and 2028. The RFID in pharmaceutical market is envisaged to record a CAGR of over 8% through 2028.

RADIO-FREQUENCY IDENTIFICATION (RFID) IN PHARMACEUTICALS MARKET TAXONOMY

The global gene editing tools market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Component

RFID Readers

RFID Tags

RFID Middleware

By Type

Chipped RFID

Chipless RFID

By Application

Drug Tracing System

Drug Quality Management

Others

By End Use

Drug Manufacturer

Drug Wholesalers

Hospitals and Clinics

Others

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/9508

Region

North America

Latin America

Western Europe

Asia Pacific Excluding Japan

Eastern Europe

Middle East and Africa

Japan